Clinical Comparison of COVID Waves 2–5. An Inpatient Retrospective Comparative Analysis From Karachi, Pakistan - Scorecard - MDSpire

Clinical Comparison of COVID Waves 2–5. An Inpatient Retrospective Comparative Analysis From Karachi, Pakistan

  • By

  • Muneeba Ahsan Sayeed

  • Elisha Shalim

  • Shaiza Farman

  • Fizza Farooqui

  • Beenish Syed

  • Ishfaque Ahmed

  • Anika Iqbal

  • Aneel Kumar

  • Raniyah Akhter

  • Furkan Hyder

  • Hasan Ali Shah

  • Adeel Hussain

  • Sarwat Rasheed

  • Saba Afshan

  • Rizwana Salik Nukrich

  • Madiha Raza

  • Haseeb U Rehman

  • Abdul Razzaque Memon

  • Abdul Wahid Rajput

  • Muhammad Saeed Quraishy

  • February 7, 2025

  • 0 min

Share

Clinical Scorecard: Comparative Clinical Analysis of COVID-19 Waves 2 to 5: A Retrospective Study of Inpatient Data from Karachi, Pakistan

At a Glance

CategoryDetail
ConditionCOVID-19 infection caused by SARS-CoV-2
Key MechanismsSARS-CoV-2 binds to ACE2 receptors in various organs; different variants (Beta, B.1.1.7, Delta, Omicron) influence disease severity and outcomes
Target PopulationAdult inpatients (>16 years) with PCR-confirmed COVID-19 admitted to a specialized infectious diseases hospital in Karachi, Pakistan
Care SettingInpatient hospital setting at Sindh Infectious Diseases Hospital & Research Center

Key Highlights

  • Wave 2 had the highest discharge rate (81%) and lowest mortality (18.9%) among waves 2 to 5.
  • Wave 4 (Delta variant) showed the highest disease severity with predominant severe COVID on admission (79.4%), highest intubation (27.1%), septic shock (24.3%), disease progression (50.8%), and mortality (42.5%).
  • Wave 5 (Omicron variant) involved mostly elderly patients with mild disease (22.4%), high comorbidity prevalence (84.6%), and increased acute kidney injury (29.2%).

Guideline-Based Recommendations

Diagnosis

  • Confirm COVID-19 infection via nasopharyngeal/oropharyngeal swab PCR testing.
  • Assess disease severity on admission to guide management.

Management

  • Implement supportive care tailored to disease severity, including oxygen therapy and mechanical ventilation as needed.
  • Monitor and manage complications such as cytokine release syndrome, septic shock, and acute kidney injury.
  • Vaccination rollout is critical to reduce severity and mortality.

Monitoring & Follow-up

  • Monitor for disease progression, especially in severe cases (notably in wave 4).
  • Regularly assess for organ dysfunction including respiratory failure and acute kidney injury.
  • Track clinical parameters to identify cytokine release syndrome.

Risks

  • Advanced age and presence of comorbidities increase risk of severe disease and complications.
  • Emergence of more virulent variants (e.g., Delta) correlates with higher mortality and severity.
  • Delayed or inadequate treatment may worsen outcomes.

Patient & Prescribing Data

Adult hospitalized COVID-19 patients in Karachi during waves 2 to 5

Mortality and severity varied by wave and variant; vaccination and emerging therapies contributed to improved survival post-wave 2.

Clinical Best Practices

  • Early identification and classification of disease severity on admission to optimize resource allocation.
  • Close monitoring for cytokine release syndrome and septic shock, especially during waves with higher severity.
  • Prioritize vaccination to reduce disease severity and mortality.
  • Adapt clinical management protocols according to predominant circulating variant and observed clinical patterns.

References

Original Source(s)

Related Content